Orthocell Limited (ASX:OCC) Submits FDA Application for Remplir™
Orthocell submits its FDA application for Remplir™, targeting the US nerve repair market, with clearance expected by April 2025.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Elders Limited (ASX:ELD) 2024 AGM Highlights
Elders Limited outlines key financial results and strategic initiatives during its 2024 AGM, marking a resilient outlook for FY25.
Magellan Global Equities Fund (ASX:MHG) Announces Final Distribution
Magellan Global Equities Fund (ASX:MHG) declares a final distribution of 6.61 cents per unit for the period ended December 31, 2024.
Imugene Limited (ASX:IMU) Confirms $11 Million R&D Tax Refund
Imugene Limited (ASX:IMU) secures $11 million R&D tax refund to advance its immuno-oncology therapies.
ARENA REIT (ASX:ARF) Announces Quarterly Dividend Distribution
ARENA REIT announces a quarterly dividend of AUD 0.045625 per unit, with key dates for investors around year-end.
ABx Group Limited (ASX: ABX) Secures $1M Loan for ALCORE
ABx Group’s subsidiary ALCORE receives a $1 million loan from Tasmania to support its innovative pilot plant for industrial chemical production.
VEEM Limited (ASX: VEE) Updates Financial Expectations for FY25
VEEM Limited revises its FY25 financial expectations and highlights operational improvements and future growth opportunities.
EBR Systems, Inc. (ASX:EBR) Schedules FDA Pre-Approval Inspection
EBR Systems, Inc. announces a scheduled FDA Pre-Approval Inspection for its wireless cardiac pacing device, a pivotal step in regulatory progress.
Arena REIT Limited (ASX:ARF) Reports $7 Million Portfolio Revaluation Increase
Arena REIT (ASX:ARF) reports a $7 million portfolio revaluation increase, focusing on healthcare and early learning acquisitions.
Vonex Limited (ASX:VN8) Director Sells Shares Amid MaxoTel Takeover
Vonex Limited Director Jason Gomersall sells shares as MaxoTel takes majority control in ongoing takeover discussions.